Lu AF28996 in Participants With Parkinson's Disease (PD)
Status:
Recruiting
Trial end date:
2022-07-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety of Lu AF28996, how well it is
tolerated and what the body does to the drug in participants with Parkinson's disease.